The landscape of high-growth enterprises in Europe's pharmaceutical sector reveals significant concentration in Italy, leading with 72 enterprises. The Czech Republic follows with 36, while Portugal accounts for 18. Smaller markets like Latvia, Slovakia, and Lithuania each report fewer than 10 enterprises. In 2023, notable year-on-year growth was evident, especially in Latvia at 51.57% and the Czech Republic at 35.1%. Italy experienced a modest 3.37% growth, whereas Hungary, Slovakia, Norway, and Iceland saw no significant change. Over the past five years, the compound annual growth rate may illuminate strategic shifts, especially the promising developments in Latvia and the Czech Republic.
Future trends to watch include potential market expansions and increased international interest in Eastern European pharmaceutical markets. Innovations in biotechnology and digital health solutions could also catalyze growth across these regions, presenting opportunities for emerging enterprises.
Top countries in Number of High Growth Enterprises in Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Units (Enterprises) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 72 | 2023 | -1.37% | +3.37% | View data |
| 2 | 2 Czech Republic | 36 | 2023 | +12.5% | +35.1% | View data |
| 3 | 3 Portugal | 18 | 2023 | +5.88% | +9.37% | View data |
| 4 | 4 Hungary | 14 | 2023 | +7.69% | 0% | View data |
| 5 | 5 Latvia | 8 | 2023 | +14.29% | +51.57% | View data |
| 6 | 6 Slovakia | 5 | 2023 | 0% | 0% | View data |
| 7 | 7 Lithuania | 5 | 2023 | +25% | +25.74% | View data |
| 8 | 8 Romania | 4 | 2023 | +33.33% | +5.92% | View data |
| 9 | 9 Norway | 2 | 2023 | 0% | 0% | View data |
| 10 | 10 Iceland | 2 | 2023 | 0% | 0% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
